Clinical Trials Browser

Phase 3 × apixaban × Plasma cell × Clear all

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism